Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$356,694
+$5,217 QoQ
Shares Held
2,276
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,039
of 1,603 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VIAWEALTH, LLC holds $8,441,332 across 7 Drug Manufacturers - General names. NVS ranks #6 (4.2% of the industry book) .
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $356,694 | 2,276 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $351,477 | 2,301 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $317,238 | 2,301 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $345,735 | 2,696 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $358,552 | 2,963 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $348,820 | 3,129 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $304,482 | 3,129 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $368,409 | 3,203 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $340,991 | 3,203 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $291,931 | 3,018 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $304,727 | 3,018 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $307,413 | 3,018 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $304,546 | 3,018 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $277,656 | 3,018 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $273,792 | 3,018 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||